In conclusion, our study revealed that MRT can initiate a cascade of innate (Tregs) and adaptive (CD8 and B cells) immune responses, which mitigate the immunosuppressive tumor microenvironment to an immune responsive one. The gene discussed is CD8A; the disease is neoplasm.